SCHEMBL845098

SCHEMBL845098

CC(=O)N1CC=C[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3C=CCN3C(=O)Cc3ccncc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 1/20 0.43
ITGA4 P13612 1/20 0.43
GLA P06280 1/20 0.39
TSHR P16473 1/20 0.37
HDAC1 Q13547 1/20 0.36
LMNA P02545 4/20 0.35
KDM4E B2RXH2 2/20 0.35
POLB P06746 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 5/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 2/20 0.34
HTT P42858 2/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
RAB9A P51151 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845099 0.96 ITGB1 (0.44) ITGB1ITGA4GLATSHRHDAC1
SCHEMBL845351 0.89 ITGB1 (0.41) ITGB1ITGA4POLBMAPTKMT2A
SCHEMBL872553 0.87 ITGB1 (0.39) ITGB1ITGA4GLATSHRHDAC1
SCHEMBL845097 0.85 NAMPT (0.39) ITGB1ITGA4LMNAKDM4EPOLB
SCHEMBL845622 0.84 ITGB1 (0.42) ITGB1ITGA4POLBALDH1A1HTT
SCHEMBL845086 0.83 EPHX2 (0.40) ITGB1ITGA4KDM4EMAPTHPGD
SCHEMBL845214 0.81 ITGB1 (0.39) ITGB1ITGA4LMNAKDM4EMAPT
SCHEMBL844923 0.79 ALDH1A1 (0.43) ITGB1ITGA4GLALMNAKDM4E
SCHEMBL845190 0.79 EPHX2 (0.42) ITGB1ITGA4HPGDMAPK1KMT2A
SCHEMBL845334 0.77 ITGB1 (0.39) ITGB1ITGA4HDAC1POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed